Tuesday, March 25, 2025
49.2 F
New York

Tag: cancer screening guidelines

Who Should Get Genetic Testing for Breast Cancer? New Guidelines, Risk Criteria, and What Patients Need to Know

Genetic testing for breast cancer has become one of the most powerful tools in modern oncology. With ongoing advances in genomic research, medical professionals are better equipped to identify individuals at elevated risk, personalize treatment plans, and guide preventive care strategies. Understanding who should get genetic testing for breast cancer is more important than ever, especially as new guidelines broaden eligibility. This article explores the clinical value of genetic testing, recent updates to testing criteria, the role of family history, and how accurate genetic testing is in determining risk.

Top Cancers in America: Understanding the Most Common Cancer in the US and the Urgent Need for Targeted Prevention

Cancer remains one of the most formidable public health challenges facing the United States today. As a leading cause of death across all demographic groups, cancer's impact stretches far beyond hospitals and laboratories—it touches families, communities, and the very fabric of the healthcare system. Understanding which cancers are most prevalent and deadliest in the US is not just an exercise in epidemiology; it is a call to action for targeted prevention, equitable healthcare access, and evidence-based policy-making. With an aging population and rising lifestyle-related risk factors, now more than ever, it is critical to examine the top cancers in America and understand their incidence, causes, treatment advances, and, most importantly, how to prevent them.

Is Cancer Becoming Less Deadly? What New Data on Cancer Rates and Survival Reveal About the Most Common Cancers

The landscape of cancer diagnosis, treatment, and survival has undergone significant transformation over the past few decades. Once synonymous with a near-certain fatal prognosis, cancer is increasingly being met with advanced diagnostic tools, targeted therapies, and innovative research that are changing patient outcomes. Yet, amid these advancements, a persistent question lingers in the public discourse and medical community alike: is cancer becoming less deadly? To answer this, we must delve into the latest epidemiological data, explore shifts in cancer survival rates, and understand how emerging technologies are reshaping the narrative. At the heart of this exploration lies a deeper understanding of the most common cancers and the changing probability of getting cancer in a lifetime.